Arnatar Therapeutics Funding: $52M Raised, Series A (2024)
Arnatar Therapeutics is a Biotech company based in San Diego, California. It has raised $52M in total funding. Latest round: Series A.
Arnatar Therapeutics funding overview
Arnatar Therapeutics is a Biotech company based in San Diego, California. Arnatar Therapeutics has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Arnatar Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Eight Roads, 3E Bioventures Capital. 2 distinct backers are named across the disclosed rounds.
Arnatar Therapeutics at a glance
Total raised
$52M
Latest round
Series A
Latest round date
January 2024
Industry
Biotech
Headquarters
San Diego, California
Notable investors
Eight Roads, 3E Bioventures Capital
Frequently asked about Arnatar Therapeutics funding
How much has Arnatar Therapeutics raised?
Arnatar Therapeutics has raised $52M in total disclosed funding across the rounds on record.
Who has invested in Arnatar Therapeutics?
Eight Roads, 3E Bioventures Capital are named among the investors backing Arnatar Therapeutics.
What was the latest Arnatar Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Arnatar Therapeutics based?
Arnatar Therapeutics is based in San Diego, California.
What sector does Arnatar Therapeutics operate in?
Arnatar Therapeutics is tracked under Biotech from San Diego, California, with $52M in disclosed funding.
When did Arnatar Therapeutics last raise?
The last disclosed Arnatar Therapeutics round closed in January 2024 at Series A.
Totals shown for Arnatar Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Diego and the investors behind them below.
